首页> 外文期刊>QJM: Monthly journal of the Association of Physicians >Localization of neuroendocrine tumours with~111 InDTPA- octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging
【24h】

Localization of neuroendocrine tumours with~111 InDTPA- octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging

机译:Localization of neuroendocrine tumours with~111 InDTPA- octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging

获取原文
获取原文并翻译 | 示例
           

摘要

A wide variety of neuroendocrine tumours express somatostatinreceptors, and can be visualized by radiolabelled somatostatinanalogue scintigraphy. To investigate the value of [~111In]-octreotide scinti- graphy (Octreoscan), 48 patients (37 withproven cacinoid, pancreatic endocrine and medullary car- cinoma ofthyroid tumours, 11 with neuroendocrine syndromes multiple endocrineneoplasia (MEN-I) and Zollinger-Ellison syndrome(ZES) were examinedwith ~111In - DTPA - D - Phe~1 - octreotide.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号